The Changing Environment Around Accelerated Approvals and Regulatory Pathways
PharmaTalkRadio7 Okt 2022

The Changing Environment Around Accelerated Approvals and Regulatory Pathways

In this session recorded at CMO Summit 2022, panelists share strategy trends and opportunities around accelerated approvals and regulatory designations. Additionally, they discuss: How to approach the FDA based on the different types of meetingsHow these trends and pathways affect trial designImplications after approval based on the pathway Speakers: Edith Perez, MD, CMO, Bolt BiotherapeuticsJeffrey Bornstein, MD, CMO, Eledon PharmaceuticalsAmy Blawas, PhD, Principal Consultant, NDA Group

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rss-nysgjerrige-norge
romkapsel
liberal-halvtime
jss
rekommandert
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
sinnsyn
villmarksliv
fjellsportpodden
smart-forklart
vett-og-vitenskap-med-gaute-einevoll
dekodet-2
rss-rekommandert
diagnose
rss-overskuddsliv
abels-tarn
kvinnehelsepodden